Kawabata, Yasunari <br/><br/>
Prognostic Value of Excision Repair Cross-Complementing Gene 1, Dihydropyrimidine Dehydrogenase, and Human Equilibrative Nucleotide Transporter 1 Expression and Their Implications for Adjuvant Treatment in Patients With Ampullary Carcinoma.  [electronic resource] 

 -  Pancreas  Aug 2015 
 - 937-44 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1536-4828 
<br/><br/><label>Standard No.: </label>10.1097/MPA.0000000000000348  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Ampulla of Vater--enzymology<br/>Biomarkers, Tumor--analysis<br/>Carcinoma--enzymology<br/>Chemotherapy, Adjuvant<br/>Chi-Square Distribution<br/>Common Bile Duct Neoplasms--enzymology<br/>DNA-Binding Proteins--analysis<br/>Dihydrouracil Dehydrogenase (NADP)--analysis<br/>Disease Progression<br/>Disease-Free Survival<br/>Endonucleases--analysis<br/>Equilibrative Nucleoside Transporter 1--analysis<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Neoplasm Recurrence, Local<br/>Pancreaticoduodenectomy--adverse effects<br/>Patient Selection<br/>Proportional Hazards Models<br/>Retrospective Studies<br/>Risk Factors<br/>Time Factors<br/>Treatment Outcome